The CD11+c cell is on the frontline of the body’s response to HIV, and new research provides promise for treatment.
ViiV Healthcare makes progress in developing a monthly injectable to treat HIV.
The gene editing technique is highly controversial, but could it be worth it?
The disease which HIV once claimed many victims to is close to a working treatment.
The Campbell Foundation bestows large grant to Stanford researchers to continue developing an HIV drug resistance test.
The study's findings done in Brazil were presented at the #AIDS 2018 global HIV conference in Amsterdam.
The National Institutes of Health announced the launch of a large scale clinical trial that will expand efforts to give more HIV positive transplant candidates new kidneys.
